Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aaron Bare

Orthopaedic Surgery Warrenville, IL Medical Doctor

NPI 1902869670 CMS profile 313728

27650 Ferry Rd, Suite 100, Warrenville, IL 60555

Open in the dashboard

General payments

$174,731

179 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Aaron Bare of Warrenville, IL is reported in the CMS Open Payments database as having received $174,731 across 179 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21,489 25
2024 General $18,785 13
2023 General $13,602 26
2022 General $36,591 31
2021 General $27,540 38
2020 General $24,057 11
2019 General $32,666 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aaron Bare
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Aaron Bare were reported at $21,489. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Aaron Bare Orthopaedic Surgery median Middle half National median
2019 $32,666 $644 $140–$2,844 $163
2020 $24,057 $312 $75–$1,860 $114
2021 $27,540 $520 $117–$2,495 $132
2022 $36,591 $598 $128–$2,731 $149
2023 $13,602 $461 $128–$2,264 $160
2024 $18,785 $497 $134–$2,475 $164
2025 $21,489 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $74,501 46 payments
  2. Catalyst OrthoScience $64,747 50 payments
  3. Stryker Corporation $18,944 41 payments
  4. DePuy Synthes Products, Inc. $9,410 7 payments
  5. Arthrex, Inc. $2,466 7 payments
  6. Wright Medical Technology, Inc. $1,890 5 payments
  7. Medwest Associates $1,543 5 payments
  8. DePuy Synthes Sales Inc. $784 12 payments
  9. Lima USA, Inc. $288 4 payments
  10. Oak Med, Inc. $133 1 payment
  11. Other $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $156,535 49 payments
  2. Food and Beverage $7,267 96 payments
  3. Travel and Lodging $6,930 30 payments
  4. Education $3,355 3 payments
  5. Gift $644 1 payment
Products named General payments · program years 2019–2025
  1. Catalyst Total CSR $35,680 20 payments
  2. EXPAREL $19,032 9 payments
  3. HEALIX $13,314 10 payments
  4. AEQUALIS PERFORM $11,446 4 payments
  5. AEQUALIS PERFORM REVERSED $10,764 4 payments
  6. Catalyst CSR Shoulder System $10,500 2 payments
  7. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $10,087 35 payments
  8. GRYPHON $8,364 13 payments
  9. OMNISPAN $7,069 2 payments
  10. CAPITAL EQUIPMENT CART $7,069 2 payments
  11. Other $67,837 99 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

29

Median for Orthopedic Surgery: 203

Drug cost

$47

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 29 $47

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 73 billing codes

Paid by Medicare

$348,045

Of which drugs: $4,611

Medicare patients

921

Average age 73

Services billed

2,873

532 women, 389 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Ischemic heart disease 24%
Diabetes 23%
Depression 21%
Chronic kidney disease 18%
Osteoporosis 18%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 199 476 $2,555

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

179 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record